Precision medicine, immunotherapy discussed at Weill Cornell Medicine

The director of the National Cancer Institute discussed advances in precision medicine and immunotherapy to treat cancer at Weill Cornell Medicine March 15.

Cancer symposium aims to unify Cornell researchers

Cornell will hold the first Annual Cancer Research Symposium to showcase diverse and groundbreaking cancer research on campus, and to better integrate investigators from the Ithaca campus and Weill Cornell Medicine.

Medical students celebrate Match Day success

Weill Cornell Medicine celebrated a successful Match Day, with 94 percent of the class matching to postgraduate positions at academic medical centers ranked in the top 50 by U.S. News and World Report.

Cornell Center for Health Equity established

Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have established a new center to better understand why health outcomes vary among demographic groups.

Genetic variation in cells' protein-building may have health implications

New research suggests genetic variation in the most essential component of the ribosome, ribosomal RNA, may influence how much and which proteins are made.

Nervous system puts the brakes on inflammation

Cells in the nervous system can “put the brakes” on immune response to infections to prevent excessive inflammation.

NYC high schoolers explore STEM fields at Weill Cornell Medicine

On Feb. 27, 90 students from public high schools across New York City participated in Big Red STEM Day, designed to inspire high school students to consider STEM fields.

Drukier Prize in Children's Health Research awarded to Harvard hematologist

Dr. Vijay Sankaran, who investigates molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research.

Blood transfusions decline 2011-14, new study finds

A Feb. 27 by Weill Cornell Medicine and other investigators reveals that blood transfusions are declining nationally.